Research has shown that breast cancer cells harboring Tekt4 germline mutations were associated with resistance to paclitaxel-based chemotherapy by stabilizing the tubulin structure in doublet microtubules [53]. The gene discussed is TEKT4; the disease is breast carcinoma.